There are well-established disparities in cancer incidence and outcomes by race/ethnicity
that result from the interplay between structural, socioeconomic, socio-environmental …

Triple-negative breast cancer accounted for 12% of breast cancers diagnosed in the United
States from 2012 to 2016, with a 5-year survival 8% to 16% lower than hormone receptor …

The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been
reported in single populations, with the majority of reports focused on White in Europe and …

Importance Variant reclassification is an important component of hereditary cancer genetic
testing; however, there are few published data quantifying the prevalence of reclassification …

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that
disproportionately affects BRCA1 mutation carriers and young women of African origin …

Triple negative breast cancer (TNBC) is a molecularly heterogeneous disease whose
incidence is disproportionately higher in African American (AA) women compared to …

Background Genetic testing for risk of hereditary cancer can help patients to make important
decisions about prevention or early detection. US and UK studies show that people from …

It is well known that there is a significant racial divide in breast cancer incidence and
mortality rates. African American women are less likely to be diagnosed with breast cancer …

Many factors including genetic, environmental, and acquired are involved in breast cancer
development across various societies. Among all of these factors in families with a history of …

BACKGROUND Breast carcinomas in African–American patients appear to be more
aggressive than in Caucasian patients due to multifactorial differences. METHODS The …